REPEAT SCREENING ADHERENCE

High adherence continues after an initial Cologuard® test screening1,2

Cologuard patients are likely to adhere to follow-up colonoscopy and future screening1,2

Separate studies demonstrated outcomes after positive and negative Cologuard results.

After a positive test result:

77%

of patients were adherent to a follow-up
colonoscopy within 1 year1*

After a negative test result:

83%

of patients were adherent to their second Cologuard screening after 3 years2†

93%

of patients were adherent to their third Cologuard screening after 6 years2†

Offer the Cologuard test to average-risk patients and prioritize colonoscopy for those who need it most.3,4

Cologuard box.

Better outcomes with the Cologuard test

Discover adherence data for initial screening with the Cologuard test.

Colorectal Cancer Screening: Where Are We Headed?

Listen to an expert panel discuss the role of the Cologuard and Cologuard Plus™ tests in addressing the CRC challenge and ensuring patients adhere to routine CRC screening.

All panelists are paid speakers, presenting on behalf of Exact Sciences. Views, opinions, and information provided during this presentation are based on the speakers’ own clinical practice and experience and are not clinical, diagnostic, or treatment advice for any particular event. Exact Sciences does not recommend or endorse any particular course of treatment or medical choice.

Screen your eligible patients for colorectal cancer (CRC) every 3 years with the Cologuard test to help increase adherence1,5,6

Send the Cologuard Rescreening Letter found in the Screening Communication Toolkit for HCPs when your patients become eligible to screen again with the Cologuard test.

Patients are eligible for rescreening with the Cologuard test if they5-7:

Are aged 45 years or older

Are at average risk for CRC

Received a negative test result with previous Cologuard screening


PROVIDER STATUS REPORT

Get screening updates for your eligible patients

Sign up for biweekly fax updates summarizing which of your patients are due for rescreening with the Provider Status Report Enrollment Form. Forms are available for both single and multiple office locations.



  • *Based on a retrospective cohort analysis of 362,646 patients aged 45-75 who received a positive result between January 1, 2017 and June 30, 2022, with the first result serving as the index date.1
  • Based on a retrospective cohort study of 793,567 patients aged 45-85 years who received a Cologuard kit between January 1 and December 31, 2023, and who had received a negative result at least 2.5 years ago.2

HCP=healthcare provider.